Table 3. The comparison between HGK levels in T cells and IL-6-producing T cells from IGT and T2D patients.
Patient | HGK levels (fold) | IL-6-producing T (%) | BMI |
---|---|---|---|
T2D #1 | 0.25 | 13.4 | 22.9 |
T2D #2 | 0.08 | 15.70 | 30.5 |
T2D #3 | 0.04 | 14.00 | 22.1 |
T2D #4 | 0.1 | 13.90 | 23.3 |
T2D #5 | 0.29 | ND | 22.2 |
T2D #6 | 0.01 | 37.50 | 21.9 |
T2D #7 | 0.52 | 10.40 | 26.8 |
T2D #8 | 0.14 | 11.80 | 22.6 |
T2D #9 | 0.11 | 26.80 | 22.2 |
T2D #10 | 0.62 | 10.00 | 26.6 |
T2D #11 | 2.19 | 9.00 | 23.9 |
IGT #1 | 0.97 | 15.00 | 28.1 |
IGT #2 | 3.69 | 2.49 | 25.2 |
IGT #3 | 0.53 | 11.80 | 21.7 |
IGT #4 | 0.25 | 16.70 | 27.5 |
HC #1 | 1.00 | 9.80 | 21.8 |
HC #2 | 1.09 | 10.00 | 21.2 |
HC #3 | 3.72 | 3.36 | 25.3 |
HC #4 | 1.00 | 6.09 | 21.8 |
HC #5 | 1.00 | 4.88 | 20.5 |
HC #6 | 0.81 | 9.00 | 28.8 |
HC #7 | 1.00 | 7.38 | 20.7 |
HC #8 | 1.53 | 4.57 | 20.2 |
HC #9 | 1.00 | 3.31 | 25.3 |
Shown are the level of HGK expression and the frequency of IL-6-producing T cells in individual IGT or T2D patients whose immunoblot data were available. The frequency of IL-6-producing T cells for one patient (#5) was not determined (ND). Fold denotes HGK levels of individual samples relative to that of the first healthy control on each membrane (Figure 1A).